JY
HURA

Jeff Yass’s TuHURA Biosciences HURA Stock Holding History

Jeff Yass’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.2K Sell
13,350
-17,497
-57% -$40.8K ﹤0.01% 12950
2026
Q1 		$55.2K Buy
+30,847
New +$37.8K ﹤0.01% 12611
2025
Q3 		– Sell
-33,599
Closed -$74.9K – 14236
2025
Q2 		$74.9K Buy
33,599
+19,801
+144% +$66.9K ﹤0.01% 11948
2025
Q1 		$44.6K Buy
+13,798
New +$50.9K ﹤0.01% 11899
2024
Q4 		– Sell
-3,649
Closed -$24.9K – 13464
2024
Q3 		$24.9K Buy
3,649
+527
+17% +$3.92K ﹤0.01% 11579
2024
Q2 		$29.5K Buy
3,122
+242
+8% +$1.51K ﹤0.01% 11574
2024
Q1 		$10.5K Buy
+2,880
New +$11.6K ﹤0.01% 11903
2023
Q2 		– Sell
-305
Closed -$39.2K – 13335
2023
Q1 		$39.2K Buy
+305
New +$58.9K ﹤0.01% 11803
2022
Q1 		– Sell
-18
Closed -$16K – 14140
2021
Q4 		$16K Buy
+18
New +$24.3K ﹤0.01% 12869
2020
Q2 		– Sell
-26
Closed -$17K – 11087
2020
Q1 		$17K Buy
+26
New +$24.2K ﹤0.01% 9971
2017
Q4 		– Sell
-21
Closed -$306K – 10025
2017
Q3 		$306K Buy
+21
New +$575K ﹤0.01% 7353

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Jeff Yass's HURA Position: Q2 2026 in Review

Jeff Yass reduced its TuHURA Biosciences (HURA) stake by 57% in Q2 2026, selling an estimated $40.8K and leaving 13,350 shares worth $31.2K. The position accounts for ﹤0.01% of the portfolio, ranked #12950.

Jeff Yass first reported a position in HURA in Q3 2017 and has held it in 11 quarters since. The position peaked at $306K in Q3 2017. 90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Jeff Yass held 13,350 shares of TuHURA Biosciences worth $31.2K as of Q2 2026.
  • Jeff Yass sold 17,497 TuHURA Biosciences shares in Q2 2026, an estimated $40.8K.
  • TuHURA Biosciences made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12950 holding.
  • Jeff Yass first reported a position in TuHURA Biosciences in Q3 2017 and has held it in 11 quarters since.
  • Jeff Yass's TuHURA Biosciences position peaked at $306K in Q3 2017.
  • 90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.